Literature DB >> 21793579

Cyclopropylhydroxycarbene.

David Ley1, Dennis Gerbig, J Philipp Wagner, Hans P Reisenauer, Peter R Schreiner.   

Abstract

Cyclopropylhydroxycarbene was generated by high-vacuum flash pyrolysis of cyclopropylglyoxylic acid at 960 °C. The pyrolysis products were matrix-isolated in solid Ar at 11 K and characterized by means of IR spectroscopy. Upon photolysis, the carbene undergoes ring expansion, thereby paralleling the reactivity of other known cyclopropylcarbenes. The ring expansion product, cyclobut-1-en-1-ol, was characterized for the first time. Matrix-isolated cyclopropylhydroxycarbene undergoes [1,2]H-tunneling through a barrier of approximately 30 kcal·mol(-1), yielding cyclopropylcarboxaldehyde. The cyclopropyl moiety acts as a π-donor and increases the half-life by almost a factor of 10 compared to parent hydroxymethylene, resulting in a temperature-independent half-life of τ = 17.8 h at both 11 and 20 K. Hence, cyclopropylhydroxycarbene is the first hydroxycarbene that differs from other members of its family by a significantly prolonged half-life. As expected, the O-deuterated analogue does not show tunneling. Our findings are rationalized by accurate CCSD(T)/cc-pVnZ (n = D, T)//M06-2X/6-311++G(d,p) computations. The half-life of cyclopropylhydroxycarbene was verified by tunneling computations employing the Wentzel-Kramers-Brillouin formalism. By comparison with other experimentally known hydroxycarbenes, we determine the electronic donor capabilities of the carbenes' substituents to be a dominant factor governing their half-lives.

Entities:  

Year:  2011        PMID: 21793579     DOI: 10.1021/ja204507j

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  1 in total

1.  Evidence for tunneling in base-catalyzed isomerization of glyceraldehyde to dihydroxyacetone by hydride shift under formose conditions.

Authors:  Liang Cheng; Charles Doubleday; Ronald Breslow
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-23       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.